These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22081106)

  • 1. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
    Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Puricelli WP; Nishioka NS
    Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
    Wolfsen HC
    J Clin Gastroenterol; 2005 Mar; 39(3):189-202. PubMed ID: 15718860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus.
    Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY
    Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
    Foroulis CN; Thorpe JA
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
    Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients.
    Weiss AA; Wiesinger HA; Owen D
    Can J Gastroenterol; 2006 Apr; 20(4):261-4. PubMed ID: 16609754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
    Gray J; Fullarton GM
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
    Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
    Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy in Barrett's esophagus.
    Overholt BF; Panjehpour M
    J Clin Laser Med Surg; 1996 Oct; 14(5):245-9. PubMed ID: 9612190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
    Panjehpour M; Overholt BF
    Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.
    Overholt BF; Panjehpour M; Halberg DL
    Gastrointest Endosc; 2003 Aug; 58(2):183-8. PubMed ID: 12872083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia.
    Wolfsen HC
    Compr Ther; 2005; 31(2):137-44. PubMed ID: 15901944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus.
    Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fléjou JF
    Gastrointest Endosc; 2004 Jun; 59(7):880-9. PubMed ID: 15173809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
    World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic ablative therapy for Barrett's esophagus: a potential cause of eosinophilic esophagitis.
    Owens VL; Katzka DA; Lutzke LS; Wang KK; Smyrk TC
    Dis Esophagus; 2012 Jan; 25(1):33-9. PubMed ID: 21668572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.
    Panjehpour M; Coppola D; Overholt BF; Vo-Dinh T; Overholt S
    Anticancer Res; 2008; 28(1B):485-9. PubMed ID: 18383889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.